Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02601209
Title Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

fibrous histiocytoma

leiomyosarcoma

malignant peripheral nerve sheath tumor

synovial sarcoma

sarcoma

Therapies

Pazopanib

Sapanisertib

Age Groups: adult
Covered Countries USA


No variant requirements are available.